MONROVIA, CA, March 27, 2012 (Press-News.org) Alexander Meissner, Assistant Professor at Harvard University will give a keynote presentation on ¡°DNA Methylation Dynamics in Development and Stem Cells¡± at the 2nd Epigenetics in Drug Discovery Conference taking place on May 30-31, 2012 in Boston, MA.
Cytosine methylation in mammals is an epigenetic modification that is largely restricted to CpG dinucleotides and serves multiple critical functions including stable repression of target promoters, maintaining genomic integrity, establishing parent-specific imprinting patterns, and silencing endogenous retrotransposon activity. In somatic tissues, CpG methylation exhibits global patterns based on relative CpG density: it is unmethylated in localized CpG islands at housekeeping or developmental promoters, and hypermethylated at non-regulatory CpGs distributed elsewhere in the genome. This landscape is relatively static across all somatic tissues that have been examined to date on a genome scale, where the majority of methylated CpGs are pre-established and inherited through cell divisions.
Generally, only a small fraction of CpGs switch their methylation levels as part of an orchestrated regulatory event. By contrast, DNA methylation is much more dynamic during mouse germ-cell and pre-implantation development. Alex Meissner¡¯s presentation will provide recent insights gained through genome-scale mapping of DNA methylation in human pluripotent stem cells and murine development.
Alex Meissner trained in Rudolf Jaenisch¡¯s laboratory at the Whitehead Institute, before he joined Harvard University as assistant professor in the department of stem cell and regenerative biology in 2008. He is also a member of the Harvard Stem Cell Institute and a senior associate member of the Broad Institute. Working with his colleagues at the Broad Institute, Alex is developing and applying high-throughput bisulfite sequencing technologies for DNA methylation analysis. This should ultimately lead to creating reference epigenomes ¨C maps of what happens outside the DNA sequence -- for many cell types, with the goal of better understanding normal and diseased cellular states.
He is co-directing the NIH Reference Epigenome Mapping Center at the Broad Institute. Complementing his work on epigenomics, his lab has a major interest in cell states and how they can be altered through ectopic transcription factors. He has led several of the early studies in the induced pluripotent stem (iPS) field while in the Jaenisch lab. His lab has since then made notable contributions to the understanding of the process and he was recently named a Pew Scholar in the Biomedical Sciences.
GTC¡¯s 2nd Epigenetics in Drug Discovery conference is the only epigenetics conference that brings together a balanced mix of leading experts from the industry and academia to collaborate on the latest cutting edge research on novel mechanisms, therapeutics, technologies and diagnostics for epigenetics drug discovery. Some key discussions around epigenetics drug discovery at the conference include the role of epigenetics in human diseases such as cancer, leukaemia, neurodegenerative conditions, neuropsychiatric disorders, inflammation, etc., and cutting edge research from GlaxoSmithKline, Epizyme, Genentech, Constellation, Cellzome, RaNA Therapeutics, Pfizer, Harvard, and Massachusetts Institute of Technology.
The conference is part of the Omics Evolution Summit, which includes 6 co-located conferences and a Clinical Sequencing Workshop on May 29th. Register for the entire summit and have access to the all of the following conferences:
2nd Genomic & Proteomic Drug Discovery Conference
3rd RNAi Research & Therapeutics Conference
7th Protein Kinases in Drug Discovery Conference
2nd Next Generation Sequencing Conference
Genome-wide Partnering and Deal Making Conference
For more information, please visit http://www.gtcbio.com
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com
Alexander Meissner to speak at 2nd Epigenetics Drug Discovery conference May 30-31, 2012 Boston, MA
Alexander Meissner, Assistant Professor at Harvard University, will give a keynote presentation at the 2nd Epigenetics in Drug Discovery Conference (May 30-31, 2012 in Boston, MA)
2012-03-27
ELSE PRESS RELEASES FROM THIS DATE:
Genetic risk and stressful early infancy join to increase risk for schizophrenia
2012-03-27
Working with genetically engineered mice and the genomes of thousands of people with schizophrenia, researchers at Johns Hopkins say they now better understand how both nature and nurture can affect one's risks for schizophrenia and abnormal brain development in general.
The researchers reported in the March 2 issue of Cell that defects in a schizophrenia-risk genes and environmental stress right after birth together can lead to abnormal brain development and raise the likelihood of developing schizophrenia by nearly one and half times.
"Our study suggests that if ...
OBX Outfitters Publishes OBX Spring Training Online Resource for Outer Banks Running, Outdoor Events
2012-03-27
Casual apparel and activewear company OBX Outfitters is providing a free online resource for Outer Banks groups and organizations to publicize their springtime charity running and other outdoor events, http://www.obxspringtraining.com.
Additionally, OBX Outfitters is offering a 25% off its North Carolina-Made Find Your Stride activewear for runners and supporters of the events.
"We're committed to helping community organizations in the Outer Banks, and providing free publicity and discounts on our running shirts is just one small way we can make a contribution," ...
CDAA Web Company Announces New Client: William Buck
2012-03-27
CDAA Pty Ltd, an Australian based Certified Web Company, today announced the signing of its newest client, William Buck, a leading firm of Chartered Accountants and advisors in Australia and New Zealand.
CDAA is providing graphic design, web design, web development, web hosting and email marketing services to William Buck to help increase its brand visibility, website traffic and build new client relationships.
"We are partnering with CDAA, a leading-edge Web Company, to design and develop our new website. With CDAA we aim to ensure that our online image is ...
More energy efficient transistors through quantum tunneling
2012-03-27
Researchers at the University of Notre Dame and Pennsylvania State University have announced breakthroughs in the development of tunneling field effect transistors (TFETs), a semiconductor technology that takes advantage of the quirky behavior of electrons at the quantum level.
Transistors are the building blocks of the electronic devices that power the digital world, and much of the growth in computing power over the past 40 years has been made possible by increases in the number of transistors that can be packed onto silicon chips.
But that growth, if left to current ...
Essential tremor patient regains independence following surgery
2012-03-27
CHICAGO – For nearly 30 years, Tom Rogers' left hand would shake when he tried to use it, making even simple tasks such as drinking a glass of water, writing a check, or making a sandwich challenging. The tremor eventually became so disruptive that he lost use of his dominant hand. Rogers sought care and learned that his tremor was a symptom of Parkinson's disease, yet felt he was suffering from something different.
"I was familiar with Parkinson's because my father had it and I knew this wasn't the same," said Rogers, a 66-year-old retired truck driver who resides in ...
Boast Capital Announces SR&ED Seminar at Innovate Calgary
2012-03-27
Boast Capital announces SR&ED Seminar at Innovate Calgary on Wednesday, April 4th from 7:30-9:30am to discuss changes to the SR&ED program arising from the new federal budget.
Canada is one of the most generous countries in funding research, innovation, and experimentation, providing approximately $7 billion annually to over 30,000 companies. Over $4.5 billion of this funding pool is provided under the SR&ED program.
As a part of the Federal Budget on March 29th, 2012, significant changes are expected to the SR&ED program. This seminar will provide ...
Human noise has ripple effects on plants
2012-03-27
A growing body of research shows that birds and other animals change their behavior in response to human noise, such as the din of traffic or the hum of machinery.
But human clamor doesn't just affect animals.
Because many animals also pollinate plants or eat or disperse their seeds, human noise can have ripple effects on plants, too, finds a new study reported in the March 21, 2012, issue of the journal Proceedings of the Royal Society B.
In cases where noise has ripple effects on long-lived plants like trees, the consequences could last for decades, even after ...
Cable TV Company to Launch Telescoping Technology in Decatur, Illinois
2012-03-27
Bruce Wilson of Comcast Spotlight announced today a new interactive cable TV service called "Telescoping" that is being launched in April in the Decatur Zone that will empower advertisers to better explain their products and services in ways that a thirty or sixty second commercial spot cannot. He explained that, "Telescoping is an interactive overlay on a TV commercial that allows advertisers to free themselves from the restrictions of a thirty second commercial and extend messaging about their product or service on demand."
For some time now Comcast ...
Does the brain 'remember' antidepressants?
2012-03-27
Individuals with major depressive disorder (MDD) often undergo multiple courses of antidepressant treatment during their lives. This is because the disorder can recur despite treatment and because finding the right medication for a specific individual can take time.
While the relationship between prior treatment and the brain's response to subsequent treatment is unknown, a new study by UCLA researchers suggests that how the brain responds to antidepressant medication may be influenced by its remembering of past antidepressant exposure.
Interestingly, the researchers ...
Top priorities in biodiversity science agreed
2012-03-27
Concluding a four-year global consultation, international experts have agreed on key efforts needed to reduce the on-going loss of biodiversity and associated ecosystem services.
On Day 2 of the Planet under Pressure conference in London (planetunderpressure2012.net) March 27, leaders of the global biodiversity research programme DIVERSITAS described the urgent need to better understand the "5 Ws" -- who, what, where, when and why -- of biodiversity loss, and how humanity might mitigate it.
Human well-being depends on ecosystems like forests and coral reefs continuing ...
LAST 30 PRESS RELEASES:
Exposure to stress during early pregnancy affects offspring into adulthood
Curious blue rings in trees and shrubs reveal cold summers of the past — potentially caused by volcanic eruptions
New frontiers in organic chemistry: Synthesis of a promising mushroom-derived compound
Biodegradable nylon precursor produced through artificial photosynthesis
GenEditScan: novel k-mer analysis tool based on next-generation sequencing for foreign DNA detection in genome-edited products
Survey: While most Americans use a device to monitor their heart, few share that data with their doctor
Dolphins use a 'fat taste' system to get their mother’s milk
Clarifying the mechanism of coupled plasma fluctuations using simulations
Here’s what’s causing the Great Salt Lake to shrink, according to PSU study
Can DNA-nanoparticle motors get up to speed with motor proteins?
Childhood poverty and/or parental mental illness may double teens’ risk of violence and police contact
Fizzy water might aid weight loss by boosting glucose uptake and metabolism
Muscular strength and good physical fitness linked to lower risk of death in people with cancer
Recommendations for studying the impact of AI on young people's mental health proposed by Oxford researchers
Trump clusters: How an English lit graduate used AI to make sense of Twitter bios
Empty headed? Largest study of its kind proves ‘bird brain’ is a misnomer
Wild baboons not capable of visual self-awareness when viewing their own reflection
$14 million supports work to diversify human genome research
New study uncovers key mechanism behind learning and memory
Seeing the unseen: New method reveals ’hyperaccessible’ window in freshly replicated DNA
Extreme climate pushed thousands of lakes in West Greenland ‘across a tipping point,’ study finds
Illuminating an asymmetric gap in a topological antiferromagnet
Global public health collaboration benefits Americans, SHEA urges continued support of the World Health Organization
Astronomers thought they understood fast radio bursts. A recent one calls that into question.
AAAS announces addition of Journal of EMDR Practice and Research to Science Partner Journal program
Study of deadly dog cancer reveals new clues for improved treatment
Skin-penetrating nematodes have a love-hate relationship with carbon dioxide
Fewer than 1% of U.S. clinical drug trials enroll pregnant participants, study finds
A global majority trusts scientists, wants them to have greater role in policymaking, study finds
Transforming China’s food system: Healthy diets lead the way
[Press-News.org] Alexander Meissner to speak at 2nd Epigenetics Drug Discovery conference May 30-31, 2012 Boston, MAAlexander Meissner, Assistant Professor at Harvard University, will give a keynote presentation at the 2nd Epigenetics in Drug Discovery Conference (May 30-31, 2012 in Boston, MA)